© Yuriy K / Shutterstock.com
The Dividend Aristocrats index has always been a narrow club. Companies need at least 25 consecutive years of dividend increases to qualify for the S&P 500 version, and the roster of ETFs built to own only these stocks is even shorter. Three funds handle almost all the flows: ProShares S&P 500 Dividend Aristocrats ETF (NYSEARCA:NOBL), ProShares S&P MidCap 400 Dividend Aristocrats ETF (NYSEARCA:REGL), and First Trust S&P 500 Dividend Aristocrats Target Income ETF (NYSEARCA:KNG).
Each of the three approaches the same universe from a different angle: NOBL as the equal-weighted large-cap flagship, REGL as the overlooked mid-cap sibling, and KNG as the covered-call income variant. With the Fed Funds Target Rate sitting at 3.75% after 0.75% of cuts over the past year, and the 10-year Treasury at 4.69%, the case for owning quality dividend growers has to compete with a still-elevated risk-free rate. That competitive backdrop is what makes fund selection matter more than usual in 2026.
NOBL: The Core Large-Cap Aristocrat Vehicle
The reference implementation of the strategy is NOBL. According to the NOBL Summary Prospectus, it holds 60 equity positions drawn from the S&P 500 Dividend Aristocrats index, weighted close to equally so that no single name dominates. The largest holding, Nucor Corp. at 1.76% of assets, sits barely above the smallest, Pentair plc at 1.15%. That flat weighting is the mechanism at work, preventing mega caps from crowding out smaller Aristocrats and keeping the fund tethered to the pure dividend growth thesis rather than to the cap-weighted structure of the S&P 500.
Assets have grown to $11.07 billion, making NOBL the largest fund in the category and generally the most liquid. The expense ratio comes in at 0.35%, which is competitive with broad dividend funds. The trailing dividend yield is roughly 2%, with a trailing 12-month distribution of $2.03 per share.
Year to date, NOBL is up 13% and 16% over the past year, with shares trading near $58. Over the trailing decade, the fund has returned 160% on a total return basis. Equal weighting cuts both ways. In a market led by a handful of cap-weighted winners, NOBL will lag the S&P 500. It is built instead to shine in broader participation cycles and during drawdowns.
REGL: The Mid-Cap Cousin Most Investors Skip
The contrarian entry on this list is REGL. Franklin Templeton’s 2026 outlook highlights U.S. small-cap stocks as a leadership area for the year, and REGL is one of the few ways to gain exposure to that segment, filtered through a strict dividend growth screen. The methodology differs from NOBL, with constituents only needing 15 consecutive years of dividend increases because mid caps rarely reach the 25-year hurdle, though the discipline is otherwise the same.
Holdings look nothing like the large-cap version. The portfolio owns 65 equity positions, with top weights in Littelfuse at 1.85%, Cabot Corp., Polaris, and Chemed. Regional banks, specialty industrials, mid-cap utilities, and niche REITs such as CubeSmart and STAG Industrial round out the roster. That gives REGL a very different sector fingerprint from any large-cap dividend product: heavier on financials and industrials, lighter on consumer staples and healthcare.
Assets are $1.68 billion, a fraction of NOBL’s size. The expense ratio is 0.40%, five basis points higher than the large-cap fund but reasonable for mid-cap access. Yield sits at 2.13%, and returns have edged higher: NOBL is up both year-to-date at 15% and over the past year at 18%. Beta of 0.72 is lower than the market, which is unusual for a mid-cap product. The tradeoff is liquidity. REGL trades in smaller volumes than NOBL, and mid-cap dividend growers can lag badly when small- and mid-cap breadth deteriorates.
KNG: Dividend Aristocrats With an Income Overlay
For investors who want the Aristocrats screen but need higher current income than a 2% yield delivers, KNG is the choice. The fund owns 54 Dividend Aristocrat equities and writes covered calls against most of them, running 34 short call positions at any given time. The premium collected from selling those calls funds a distribution stream that gets paid out monthly rather than quarterly.
The result is a very different income profile. KNG’s trailing 12-month distribution totals $4.21 per share, and the fund yields around 6.1%. That comes at a cost. The expense ratio is 0.76%, more than double NOBL’s, and the covered-call overlay caps upside when Aristocrats rally hard. That shows up in the numbers: KNG is up 11% year-to-date and 14% over the past year, trailing both NOBL and REGL because gains above the strike price flow to the option buyer, not the fund.
Assets have grown to $3.37 billion, and the switch from quarterly to monthly distributions in 2024 aligned the payout cadence with what retirees actually want. Beta of 0.73 is comparable to REGL. KNG will lag in strong bull markets by design. The premium from covered calls compensates for capped participation, and in flat or choppy tape, the strategy pulls ahead. It is a total-return give-up in exchange for a substantially higher current cash yield.
Which Aristocrats Fund Fits Which Investor
For someone building a long-term core position in dividend growth, NOBL is the default choice. It is the largest, most liquid, and cheapest of the three, capturing the full Aristocrats universe without style tilts or derivatives. REGL is the fund for an investor who already owns large-cap dividend exposure and wants to add mid-cap breadth with a similar quality screen, particularly if the 2026 case for smaller caps plays out. KNG is the income solution, and retirees or investors drawing from their portfolios who value a 6% monthly distribution over capital appreciation have a legitimate use case there, provided they accept the capped upside and the higher expense ratio. Owning two of the three is defensible, though owning all three overlaps too heavily on the large-cap side to be worth the added complexity.
Contact [email protected] for any questions or corrections.